Cargando…

Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients

SIMPLE SUMMARY: The introduction of checkpoint inhibitors, such as anti-PD1 and anti-CTLA4 approaches, resulted in a breakthrough step in the outcome of advanced melanoma. However, next to the improved efficacy, a wide range of side effects appeared. During our analysis, we explored the effects and...

Descripción completa

Detalles Bibliográficos
Autores principales: Eikenes, Grethe, Liszkay, Gabriella, Balatoni, Tímea, Czirbesz, Kata, Hunyadi, Karen, Kozéki, Zsófia, Kispál, Mihály Tamás, Baranyai, Fanni, Danyi, Tímea, Bőcs, Katalin, Kenessey, István
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417734/
https://www.ncbi.nlm.nih.gov/pubmed/37568785
http://dx.doi.org/10.3390/cancers15153966